Opinion|Videos|May 16, 2024

Collaborating with Other Care Providers to Optimize Outcomes for Patients Receiving Bispecifics

The expert panel explores the importance of communication and collaboration among care providers when patients with multiple myeloma who are receiving treatment with bispecific antibodies navigate transitions of care to and from various healthcare settings.

Episodes in this series

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME